ProKidney signs SPAC merger deal with Social Capital Suvretta
ProKidney delivers disease-altering autologous cell therapy to treat chronic kidney disease.
M&A League Tables Pharma
BenevolentAI and AstraZeneca expand drug discovery partnership
Alexion to pay up to $760m for transthyretin amyloid cardiomyopathy drug
Sanofi to acquire immuno-oncology firm Amunix for $1bn
Aerami’s upcoming merger with FoxWayne will bolster the company’s PAH portfolio
Aerami’s upcoming merger with FoxWayne will bolster the company’s PAH portfolio
Thermo Fisher acquires clinical research services provider PPD for $17.4bn
Alvotech and Oaktree enter merger deal to form biopharma company
